Abstract: A magnetic nanoparticle is provided in the disclosure. The magnetic nanoparticle includes a magnetic nanoparticle; a biocompatible polymer of the following formula (II) covalently coupled to the magnetic nanoparticle, wherein R1 is alkyl, aryl, carboxyl, or amino; n is an integer from 5 to 1000; and m is an integer from 1 to 10.

Abstract: The invention provides phosphors composed of Eu(1-x)MaxMg(1-y)MbyAl(10-z)MczO17, wherein Ma is Yb, SN, Pb, Ce, Tb, Dy, Pr, Ca, Sr, Ba, or combinations thereof, and 0?x?0.9; Mb is Mn, Zn, or combinations thereof, and 0<y?0.7; Mc is Ga, In, B, or combinations thereof, and 0?z?5. These phosphors emit visible light under the excitation of ultraviolet light or blue light, and these phosphors may be further collocated with different color phosphors to provide a white light illumination device. Alternatively, the phosphors of the invention can improve the efficient utilization of the light in solar cell.

Abstract: A magnetic nanoparticle is provided in the disclosure. The magnetic nanoparticle includes a magnetic nanoparticle; a biocompatible polymer of the following formula (II) covalently coupled to the magnetic nanoparticle, wherein R1 is alkyl, aryl, carboxyl, or amino; n is an integer from 5 to 1000; and m is an integer from 1 to 10.

Abstract: The invention discloses a biocompatible polymer for covalently modifying magnetic nanoparticles. The biocompatible polymer may be coupled to a targeting agent and/or a fluorescent dye. The invention also discloses a magnetic nanoparticle with biocompatibilities comprising the biocompatible polymer.

Abstract: The invention provides phosphors composed of EuMg(1-x)MaxMb10O17, wherein Ma is Mn, Zn, or combinations thereof, Mb is Al, Ga, B, In, or combinations thereof, and O<x<0.7. These phosphors emit visible light under the excitation of ultraviolet light or blue light, and these phosphors may be further collocated with different color phosphors to provide a white light illumination device. Alternatively, the phosphors of the invention can improve the efficient utilization of the light in solar cell.

Abstract: The invention provides phosphors composed of Eu(1-x)MaxMg(1-y)MbyAl(10-z)MczO17, wherein Ma is Yb, SN, Pb, Ce, Tb, Dy, Pr, Ca, Sr, Ba, or combinations thereof, and 0?x?0.9; Mb is Mn, Zn, or combinations thereof, and 0<y?0.7; Mc is Ga, In, B, or combinations thereof, and 0?z?5. These phosphors emit visible light under the excitation of ultraviolet light or blue light, and these phosphors may be further collocated with different color phosphors to provide a white light illumination device. Alternatively, the phosphors of the invention can improve the efficient utilization of the light in solar cell.

Abstract: A core-shell structure with magnetic, thermal, and optical characteristics. The optical absorption band is tailorable by choice of the mixing ratio of the core/shell component to give the desired shell thickness. The core-shell structure is particularly suitable for biomedical applications such as MRI (magnetic resonance imaging) developer, specific tissue identification developer, and magnetic thermal therapy.

Abstract: A new antifungal formulation is provided. The present invention uses a sterol modified with polyethylene glycol (PEG) as a drug carrier. The drug carrier encapsulates Amphotericin B (AmB) by self-assembly to form polymeric micelles. The polymeric micelles can reduce toxicity of Amphotericin B and control release of Amphotericin B. The polymeric micelles of Amphotericin B are used as a new antifungal formulation.

Abstract: A dendritic polymer and a magnetic resonance imaging contrast agent employing the same. The magnetic resonance contrast agent includes the dendritic polymer according to the structure of wherein, P is ?CH2CH2O?1, and 1 is not less than 1 and j is not less than 2; D is a C3-30 dendritic moiety having n oxygen residue, and n is not less than 3 and i is more than 1; X is C3-30 moiety having bi-functional groups; Z is independent and includes a C3-20 moiety having a plurality of functional group, wherein the functional groups are selected from a group consisting of carbonyl, carboxyl, amine, ester, amide, or chelate group, and Z respectively bonds with X by a group; and L is a metal cation.

Abstract: A block copolymer. The block copolymer has formula A-B-C, wherein A represents polyester, B represents polyamide, and C represents specific molecular groups or metal complexes. The invention also provides a nano micelle and drug carrier including the block copolymer.

Abstract: A method for making a series of nanoscale microstructures, including helical microstructures and cylindrical microstructures. This method includes the steps of: (1) forming a chiral block copolymer containing a plurality of chiral first polymer blocks and a second polymer blocks wherein the chiral first polymer blocks have a volume fraction ranging from 20 to 49%; (2) causing a phase separation in the chiral block copolymer. In a preferred embodiment, the chiral block copolymer is poly(styrene)-poly(L-lactide) (PS-PLLA) chiral block copolymer, and the copolymerization process is a living copolymerization process which includes the following steps: (a) mixing styrene with BPO and 4-OH-TEMPO to form 4-hydroxy-TEMPO-terminated polystyrene; and (2) mixing the 4-hydroxy-TEMPO-terminated polystyrene with [(?3-EDBP)Li2]2[(?3-nBu)Li(0.5Et2O)]2 and L-lactide in an organic solvent preferably CH2Cl2 to form the poly(styrene)-poly(L-lactide) chiral block copolymer.

Abstract: A cadmium tin oxide (Cd1-xSnxO) multi-layer laminate is disclosed. The laminate comprises: a substrate; and a layer of Cd1-xSnxO which is not an epitaxial structure; wherein, the composition of Sn/(Cd+Sn) is 1˜20%. The method for producing the Cd1-xSnxO multi-layer laminate is also described here. The method comprises steps of: (a) providing metal or oxide targets for sputtering films of Cd1-xSnxO; and (b) sputtering films of Cd1-xSnxO from the targets onto the substrate; wherein the composition of Sn/(Cd+Sn) is 1˜20%.